Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition

The mortality and morbidity rates of pancreatic cancer are high because of its extremely invasive and metastatic nature. Its lack of symptoms, late diagnosis and chemo–resistance and the ineffective treatment modalities warrant the development of new chemo–therapeutic agents for pancreatic cancer. A...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Subramani, Ramadevi, Gonzalez, Elizabeth, Arumugam, Arunkumar, Nandy, Sushmita, Gonzalez, Viviana, Medel, Joshua, Camacho, Fernando, Ortega, Andrew, Bonkoungou, Sandrine, Narayan, Mahesh, Dwivedi, Alok kumar, Lakshmanaswamy, Rajkumar
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4726267/
https://ncbi.nlm.nih.gov/pubmed/26804739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep19819
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia